Results 31 to 40 of about 633,065 (305)

Relapse

open access: yes, 2012
Plasmodium vivax is a major cause of febrile illness in endemic areas of Asia, Central and South America, and the horn of Africa. P. vivax infections are characterized by relapses of malaria arising from persistent liver stages of the parasite (hypnozoites), which can be prevented currently only by 8-aminoquinoline anti-malarials. Tropical P.
White, N, Imwong, M
openaire   +2 more sources

Preventing smoking relapse using text messages: analysis of data from the txt2stop trial. [PDF]

open access: yes, 2012
INTRODUCTION: Interactive text message-based technologies which operate in real time have the potential to be especially effective for delivery of relapse prevention interventions.
Kenward, Michael G   +2 more
core   +1 more source

Relapsing polychondritis

open access: yesDermatology Online Journal, 2003
A 57-year-old man presented with a 2-year history of (1) recurrent swelling of the ears that spared his earlobes and (2) migratory arthralgias. A biopsy specimen of the ear showed a perichondrial infiltrate of lymphocytes, plasma cells, and a few neutrophils. There were acellular foci of underlying cartilage.
Alatas, FÜSUN   +5 more
openaire   +7 more sources

A case of visceral leishmaniasis imported from Armenia

open access: yesДетские инфекции (Москва), 2023
The relevance of the problem of visceral leishmaniasis is due to the severity of clinical manifestations, as well as the need for immediate etiotropic therapy.
A. L. Rossina   +7 more
doaj   +1 more source

Evaluation of the Efficacy of an Ecobiological Dermo-Cosmetic Product to Help Manage and Prevent Relapses of Eyelid Atopic Dermatitis

open access: yesClinical, Cosmetic and Investigational Dermatology, 2023
Sandrine Bergera-Virassamynaïk, Nathalie Ardiet, Michèle Sayag NAOS Group, Research and Development Department, Aix-en-Provence, 13290, FranceCorrespondence: Sandrine Bergera-Virassamynaïk, NAOS Group, Research and Development Department, Aix-en-Provence,
Bergera-Virassamynaïk S   +2 more
doaj  

Mindfulness and relapse prevention

open access: yes, 2020
Graber, Jennifer S.Background: The relapse rate for substance use disorders (SUD) is estimated to be between 40% to 60%. With this high rate, adjunctive interventions, such as mindfulness, that compliment pharmacological interventions to prevent relapse ...
Musau, Sylvia
core   +1 more source

Aging agricultural labor force, outsourcing service of pest control and biopesticide application: a case study of 10 counties in Fujian Province

open access: yesFrontiers in Sustainable Food Systems
IntroductionUnder the background of increasingly severe aging of agricultural labor force and relatively slow land circulation, agricultural production outsourcing has become the main means of agricultural modernization.
Doudou Shen   +3 more
doaj   +1 more source

DIAGNOSIS OF FUNDOPLICATION CUFF FAILURE IN PATIENTS OPERATED BY THE NISSEN METHOD

open access: yesВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2021
The article is devoted to the treatment of patients with hiatal hernia. The aim of the study was to develop a method for diagnosing the failure of the  fundoplication cuff in patients with recurrent hernia of the foodwater orifice of  the diaphragm after
V. K. Koryttsev   +2 more
doaj   +1 more source

Relapse-free survival.

open access: yes, 2017
Overall relapse-free survival in 37 responders with infliximab (A), relapse-free survival based on neutrophil-to-lymphocyte ratio (NLR) at the start of infliximab, the overall survival rate was significantly worse in the high NLR group than in the low ...
Kenji Watanabe (75040)   +14 more
core   +1 more source

Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse

open access: yes, 2022
Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this disease ...
Guillaume Beziat   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy